Neonatal graves disease caused by transplacental antibodies

NeoReviews

Volumn 9, Issue 7, 2008, Pages

  Hernandez, Maria Isabel ^a   Lee, Kuk Wha ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56549086780     PISSN: None     EISSN: 15269906     Source Type: Journal    
DOI: 10.1542/neo.9-7-e305     Document Type: Article

References (24)

1. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2007;92:S1-S47
2. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid. 1992;2:155-159
3. Glinoer D. Thyroid hyperfunction during pregnancy. Thyroid. 1998;8:859-864
4. O'Connor MJ, Paget-Brown AO, Clarke WL. Premature twins of a mother with Graves' disease with discordant thyroid function: a case report. J Perinatol. 2007;27:388-389
5. White C. A foetus with congenital hereditary Graves disease. J Obstet Gynaec Br Emp. 1912;21:231.
6. Zakarija M, McKenzie JM. Pregnancy-associated changes in the thyroid-stimulating antibody of Graves' disease and the relationship to neonatal hyperthyroidism. J Clin Endocrinol Metab. 1983;57: 1036-1040
7. Missero C, Cobellis G, De Felice M, Di Lauro R. Molecular events involved in differentiation of thyroid follicular cells. Mol Cell Endocrinol. 1998;25;140:37-43
8. Damante G, Di Lauro R. Thyroid-specific gene expression. Biochim Biophys Acta. 1994;1218:255-266
9. Ballabio M, Nicolini U, Jowett T, et al. Maturation of thyroid function in normal human foetuses. Clin Endocrinol (Oxf). 1989; 31:565-571
10. Contempré B, Jauniaux E, Calvo R, et al. Detection of thyroid hormones in human embryonic cavities during the first trimester of pregnancy. J Clin Endocrinol Metab. 1993;77:1719-1722
11. Fisher DA. Endocrinology of fetal development. In: Wilson JD, Foster DW, eds. Textbook of Endocrinology. Philadelphia, Pa: WB Saunders; 1999:2073-2102
12. Adams D, Purves H. Abnormal responses in the assay of thyrotrophin. Proc Univ Otago Med School. 1956;34:11
13. Radetti G, Persani L, Moroder W, et al. Transplacental passage of anti-thyroid auto-antibodies in a pregnant woman with autoimmune thyroid disease. Prenat Diagn. 1999;19:468-471
14. Nachum Z, Rakover Y, Weiner E, Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol. 2003;189:159-165
15. Major P, Munro D. Thyroid stimulating activity in human serum [abstract]. J Endocr. 1960;20:XIX
16. Polak M. Activating mutations of the thyrotropin receptor: a short review with emphasis on some pediatric aspects. Eur J Endocrinol. 1998;138:353-357
17. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid. 1999;9:727-733
18. Polak M, Le Gac I, Vuillard E, et al. Fetal and neonatal thyroid function in relation to maternal Graves' disease. Best Pract Res Clin Endocrinol Metab. 2004;18:289-302
19. Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab. 2005;90:6093-6098
20. Zakarija M, McKenzie JM, Hoffman WH. Prediction and therapy of intrauterine and late-onset neonatal hyperthyroidism. J Clin Endocrinol Metab. 1986;62:368-371
21. Ogilvy-Stuart AL. Neonatal thyroid disorders. Arch Dis Child Fetal Neonatal Ed. 2002;87:F165-F171
22. Skuza KA, Sills IN, Stene M, et al. Prediction of neonatal hyperthyroidism in infants born to mothers with Graves' disease. J Pediatr. 1996;128:264-267
23. Sunshine P, Kusumoto H, Kriss JP. Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics. 1965;36: 869-876
24. Cooper D. Antithyroid drugs. N Engl J Med. 2005;352: 905-917